Estrostep Fe Interactions
There are 495 drugs known to interact with Estrostep Fe (ethinyl estradiol/norethindrone), along with 24 disease interactions, and 9 alcohol/food interactions. Of the total drug interactions, 77 are major, 369 are moderate, and 49 are minor.
- View all 495 medications that may interact with Estrostep Fe
- View Estrostep Fe alcohol/food interactions (9)
- View Estrostep Fe disease interactions (24)
Most frequently checked interactions
View interaction reports for Estrostep Fe (ethinyl estradiol / norethindrone) and the medicines listed below.
- Aciphex (rabeprazole)
- Adderall (amphetamine / dextroamphetamine)
- Adderall XR (amphetamine / dextroamphetamine)
- albuterol
- Aleve (naproxen)
- Ambien (zolpidem)
- amitriptyline
- Ativan (lorazepam)
- Azithromycin Dose Pack (azithromycin)
- Bentyl (dicyclomine)
- biotin
- Cipro (ciprofloxacin)
- clonazepam
- clonidine
- Concerta (methylphenidate)
- Cymbalta (duloxetine)
- ibuprofen
- Lamictal (lamotrigine)
- Lyrica (pregabalin)
- metformin
- Ortho Tri-Cyclen (ethinyl estradiol / norgestimate)
- prednisone
- Seroquel (quetiapine)
- spironolactone
- trazodone
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- Yasmin (drospirenone / ethinyl estradiol)
- Zofran (ondansetron)
- Zoloft (sertraline)
Estrostep Fe alcohol/food interactions
There are 9 alcohol/food interactions with Estrostep Fe (ethinyl estradiol / norethindrone).
Estrostep Fe disease interactions
There are 24 disease interactions with Estrostep Fe (ethinyl estradiol / norethindrone) which include:
- smoking
- abnormal genital bleeding
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- breast malignancy
- liver disease
- thromboembolism
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- hyperlipidemia
- weight gain
More about Estrostep Fe (ethinyl estradiol / norethindrone)
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.